TrialBMC pharmacology & toxicology2013

Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study.

Anthony Cahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.